Intestinal flora testing uses next-generation high-throughput sequencing platform, based on the 16S rDNA sequencing technology in the Human Microbiome Project, it detects the types and quantities of human intestinal flora, and analyzes the intestinal microecological environment of the subjects ( the overall situation of the flora, the contents of probiotics and pathogenic bacteria, etc.). It is used to assess the risks of diabetes, obesity, irritable bowel syndrome, other diseases, as well as immune status, and to provide the subjects with personalized health conditioning programs, thereby promoting the balance of intestinal flora and improving the health of the subjects.